Summary
GLP-1 medications do not usually directly deplete nutrients, but they can lower intake enough to create micronutrient shortfalls in some patients.
Common clinical concerns include vitamin D, iron, and calcium; rarer issues may arise when intake is very low or food variety becomes highly restricted.
Risk is driven more by reduced appetite, nausea, vomiting, and limited food variety than by the medication itself.
Routine lab screening is not established for every GLP-1 user, so monitoring should be individualized based on diet, symptoms, and risk factors.
Medical disclaimer: This article is for education only and does not replace care from your prescribing clinician, primary care clinician, or registered dietitian. If you have persistent nausea, vomiting, rapid weight loss, dizziness, weakness, numbness, or fatigue while taking a GLP-1 medication, seek individualized medical advice.
Quick takeaways
GLP-1 medications such as semaglutide, liraglutide, and tirzepatide can make it easier to eat less, but that benefit can also make it harder to meet nutrition needs if meals become too small, too repetitive, or too limited in variety. Current evidence supports a cautious message: the medication itself is not known to directly “drain” vitamins or minerals, but reduced intake, food aversions, nausea, and vomiting can create micronutrient shortfalls in some patients. A recent narrative review found that GLP-1 and dual GIP/GLP-1 therapies reduce calorie intake, while the exact micronutrient pattern is still not well defined. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11340591/))
In practice, the most useful approach is not random supplementation. It is preserving nutrient density in smaller meals, watching for symptoms that suggest low intake, and checking labs when a patient’s history or symptoms make that appropriate. Expert guidance published in 2025 also notes that structured micronutrient monitoring protocols for GLP-1 therapy have not yet been established the way they have for bariatric surgery. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
Why GLP-1 therapy can create nutrition gaps
GLP-1 medications work partly by reducing hunger and increasing fullness, which is one reason they help with weight loss and blood sugar control. The tradeoff is that some people eat fewer meals, smaller portions, or a narrower range of foods. If that pattern lasts long enough, the issue becomes less about the drug and more about prolonged under-eating or repetitive eating habits that do not cover basic nutrient needs. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11340591/))
That matters because many nutrients are not stored in large amounts. When intake drops for weeks or months, the body may first show nonspecific signs such as fatigue, weakness, constipation, hair shedding, reduced exercise tolerance, or brain fog. Those symptoms are not specific to any one deficiency, which is why context matters: the risk is higher when appetite is low, nausea is ongoing, vomiting happens repeatedly, or food variety is very limited. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
What tends to change first
In many patients, the first nutrition changes are practical ones: skipping breakfast, eating only a few bites at meals, avoiding protein because it feels heavy, or relying on a small set of “safe” foods. Over time, that can reduce protein, fiber, and micronutrient intake even when total calories are not extremely low. The available literature supports this mechanism more strongly than it supports a specific, universal deficiency pattern for every GLP-1 user. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11340591/))
Commonly overlooked deficiencies to discuss first
When clinicians talk about GLP-1-related nutrition concerns, the most common practical discussion points are vitamin D, iron, and calcium. These are not guaranteed deficiencies, and they are not unique to GLP-1 therapy. They are simply common shortfalls that can become more likely when intake falls and food choices narrow. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
Nutrient | Why it may become low | Possible clues | Common food sources |
|---|---|---|---|
Vitamin D | Less fortified dairy or fewer nutrient-dense meals | Often silent; sometimes bone or muscle concerns | Fortified dairy, fortified alternatives, fatty fish |
Iron | Smaller portions of meat, legumes, or iron-rich foods | Fatigue, low stamina, dizziness, shortness of breath | Meat, beans, lentils, leafy greens |
Calcium | Reduced dairy or fortified food intake | Usually subtle at first; bone health concerns over time | Dairy, fortified plant milks, tofu set with calcium |
Vitamin D is worth mentioning because it is already common in many adults, so a patient may start therapy with borderline status and then drift lower if intake worsens. Iron deficiency can become more likely when people eat smaller portions or avoid iron-rich foods, especially if menstrual blood loss, pregnancy, or another risk factor is also present. Calcium deserves attention because low intake can matter for bone health, particularly when overall nutrition is reduced and vitamin D status is also low. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
Can rarer deficiencies happen?
Yes, but the evidence is less direct and the risk is usually tied to prolonged low intake, vomiting, or a very restricted diet rather than GLP-1 therapy alone. In other words, the medication is best understood as a contributor to reduced intake, not as a direct cause of a specific deficiency pattern in most patients. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11340591/))
Vitamin C shortfalls may be a concern when fruit and vegetable intake falls sharply. Thiamine (vitamin B1) can become important when total intake is very low, especially if vomiting is ongoing or food intake is prolongedly poor. Vitamin B12 and folate can also become low in some patients if the diet becomes too narrow, especially when animal protein, leafy greens, legumes, or fortified foods are consistently limited. These are clinical considerations, not universal GLP-1-specific outcomes. ([academic.oup.com](https://academic.oup.com/pmj/article/99/1174/844/7147066))
Why thiamine gets special attention
Thiamine is often discussed separately because body stores are limited and deficiency can become clinically important when intake is poor for even a relatively short period. Severe deficiency can affect the nervous system and may present with confusion, balance problems, or eye movement changes in serious cases. That is why persistent vomiting, very low intake, or rapid weight loss deserves prompt medical attention rather than just “trying to eat more later.” ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158385/))
What symptoms should make you think about a deficiency?
No symptom proves a deficiency on its own, but certain patterns should prompt a conversation with a clinician. Fatigue, reduced exercise tolerance, dizziness, weakness, hair shedding, constipation, brittle nails, tingling, poor balance, or cognitive fog can all have many causes, including low intake. The key question is whether those symptoms are happening in the setting of appetite suppression, nausea, vomiting, or a very limited diet. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
Symptoms that are more urgent include confusion, trouble walking, persistent vomiting, dehydration, fainting, chest pain, or neurologic changes such as numbness or vision changes. Those symptoms do not mean a deficiency is definitely present, but they do mean the situation should be assessed quickly. ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158385/))
How clinicians usually monitor risk
There is not yet a universal lab panel that every GLP-1 user should get on a fixed schedule. The best-supported approach is individualized monitoring based on baseline nutrition status, weight-loss pace, GI side effects, dietary pattern, and other medical risks. That is consistent with recent expert reviews and consensus-style guidance, which emphasize nutrition support but also acknowledge that direct evidence is still developing. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
For some patients, it is reasonable to discuss baseline or follow-up labs such as vitamin D, iron studies, B12, and folate, especially if intake is poor or symptoms develop. For others, the more useful first step may be a diet review rather than broad testing. The right plan depends on the person, not just the prescription. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
Monitoring question | Why it matters | Possible next step |
|---|---|---|
Has appetite dropped sharply? | Low intake can reduce nutrient density | Review meal pattern and protein intake |
Is nausea or vomiting ongoing? | Raises risk of dehydration and shortfalls | Clinician review, hydration plan, consider labs |
Is the diet repetitive or highly restricted? | Fewer food groups means fewer nutrients | Dietitian-guided food expansion |
Are there symptoms like fatigue or tingling? | May suggest anemia or B-vitamin issues | Targeted bloodwork and exam |
How to lower risk without overcomplicating eating
The goal is not to force large meals. It is to make smaller meals more complete. A practical pattern is to build each eating opportunity around protein, then add a fruit or vegetable, and then include a fortified or calcium-rich option when tolerated. This approach helps protect nutrient intake even when appetite is low. ([ajcn.nutrition.org](https://ajcn.nutrition.org/article/S0002-9165%2825%2900240-0/fulltext))
Many patients do better with simple, repeatable meals rather than ambitious meal plans. Examples include Greek yogurt with fruit, eggs with vegetables, a protein smoothie, soup with beans or chicken, cottage cheese with berries, or tofu with rice and vegetables. If nausea is prominent, bland and easy-to-tolerate foods may be a temporary bridge, but the diet should still be broadened as symptoms improve. ([sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S2667368125000725))
When supplements make sense
Supplements can be helpful when a deficiency is confirmed, when intake is predictably low, or when a clinician recommends them for a specific reason. They are not a substitute for food variety, and they are not automatically required for every GLP-1 user. The safest approach is to match the supplement to the likely gap, rather than taking a long list of products without a clear target. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
What this means for patients on GLP-1 therapy
If you are doing well on a GLP-1 medication, the main message is simple: keep the medication plan, but do not let appetite suppression turn into prolonged under-fueling. If you are struggling with nausea, food aversions, or very low intake, that is a nutrition issue worth addressing early. In many cases, the fix is straightforward once the pattern is recognized. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11340591/))
At Heald, the most useful strategy is individualized support: review what you are actually eating, identify the likely gaps, and decide whether labs, food changes, or targeted supplementation are appropriate. That is especially important because routine screening is not established for all patients, and the right plan depends on symptoms, diet quality, and other medical factors. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
Conclusion
GLP-1 medications can be highly effective, but they can also make it easier to eat too little or too narrowly. The concern is not that the drug directly strips away nutrients. The concern is that appetite suppression, nausea, vomiting, and repeated food avoidance can lead to micronutrient shortfalls in some patients, especially when the pattern lasts for weeks or months. Most of these issues are preventable or reversible when caught early. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11340591/))
If you are on a GLP-1 and notice fatigue, weakness, dizziness, tingling, persistent nausea, or a very restricted diet, bring it up with your clinician. The best next step is usually not guessing at supplements. It is a focused review of intake, symptoms, and individualized labs when indicated. That approach protects both safety and treatment success. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12693348/))
